1	Has been treated with felbamate or vigabatrin within the past 6 months prior to Screening if a subject has been previously treated with vigabatrin a visual perimetry test prior to screening or within the past 6 months must show normal visual fields or no worsening of recognized visual field abnormalities|felbamate[22,31]|||||||||C0060135|24812|24812|felbamate
1	Has been treated with felbamate or vigabatrin within the past 6 months prior to Screening if a subject has been previously treated with vigabatrin a visual perimetry test prior to screening or within the past 6 months must show normal visual fields or no worsening of recognized visual field abnormalities|vigabatrin[35,45]|||||||6 months[62,70]||C0048044|14851|14851|vigabatrin
1	Has been treated with felbamate or vigabatrin within the past 6 months prior to Screening if a subject has been previously treated with vigabatrin a visual perimetry test prior to screening or within the past 6 months must show normal visual fields or no worsening of recognized visual field abnormalities|vigabatrin[136,146]|||||||||C0048044|14851|14851|vigabatrin
2	as compared with prior to vigabatrin treatment|vigabatrin[332,342]|||||||||C0048044|14851|14851|vigabatrin
